VYSCOXA

LaunchSM

celecoxib

NDAORALSUSPENSION
Approved
Jul 2025
Lifecycle
Launch
Competitive Pressure
30/100
Clinical Trials
20

Mechanism of Action

Cyclooxygenase Inhibitors

Pharmacologic Class:

Nonsteroidal Anti-inflammatory Drug

Clinical Trials (5)

NCT05438303Phase 1Completed

Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female Volunteers

Started Jun 2022
59 enrolled
Healthy Volunteers
NCT03710876Phase 3Active Not Recruiting

Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma

Started Jan 2019
53 enrolled
Malignant Pleural Mesothelioma
NCT02934191Phase 2Completed

Celecoxib After Tonsillectomy

Started Jun 2016
172 enrolled
Tonsillectomy
NCT02688400Phase 3Completed

Effect of Diacerein vs Celecoxib on Symptoms and Structural Changes in Symptomatic Knee Osteoarthritis

Started May 2016
NCT02502500Phase 1Completed

Effect of AKB-6548 on the Pharmacokinetics of Celecoxib

Started Jul 2015